FDA Approves Product Redeeming Rare Pediatric Disease Priority Review Voucher

Summary

The FDA has approved VEOZAH (fezolinetant), a product that redeems a priority review voucher, following a review of the product's eligibility under the Federal Food, Drug, and Cosmetic Act.